The independent research organization BioMed X has finalized its oncology research initiative in collaboration with Merck, whose data has been obtained by Merck for additional development, possibly resulting in innovative therapeutic methods in...
Dr. Reddy's Laboratories announced that its subsidiary has signed a licensing agreement with Shanghai Henlius Biotech, Inc. to develop and market a cancer drug currently in development. Dr Reddy's Laboratories SA has signed an agreement with the...
Uniphar, a global partner for pharmaceutical and medtech manufacturers, is enhancing its international reach by opening three new facilities, strategically located in major global markets such as Raleigh, Lelystad, and Dublin. Uniphar's recent...
AGC Pharma Chemicals, a leader in pharmaceutical manufacturing with more than 40 years of experience in Contract Development Manufacturing Operations (CDMO) for small molecule APIs located in Barcelona (Spain) and Japan, is enhancing its High...
Jaguar Health, Inc, and Napo Therapeutics revealed that the initial patient suffering from short bowel syndrome with intestinal failure (SBS-IF) has been treated in the independently initiated pediatric proof-of-concept trial (IIT) for crofelemer...
Algiax Pharmaceuticals, a biotech company in the clinical stage that specializes in creating innovative therapies for chronic neuropathic pain, revealed promising topline results from its phase 2a clinical trial assessing AP-325 for neuropathic...
Sigachi Industries Limited, a prominent entity in the pharmaceutical sector, is setting up a research and development center in Hyderabad, unifying its essential API Innovation and analytical initiatives in one location. This strategic plan...
Ardena, a focused pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) operating in Belgium, Spain, the Netherlands, and Sweden, has finalized its acquisition of Catalent...
Industry experts from the healthcare segment made their remarks post-budget 2025. The budget strengthens India's commitment to health innovation, inclusive growth and improved access to nutrition. The exemption of around 40 life-saving drugs from...
C2 PHARMA has disclosed the approval of a Certificate of Suitability (CEP) for Oxybuprocaine Hydrochloride from the European Directorate for the Quality of Medicines and Health Care (EDQM). Oxybuprocaine Hydrochloride is presently accessible to...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")